- Home
- MIAX vs DNLI Comparison
MIAX vs DNLI Comparison
Compare MIAX & DNLI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | MIAX | DNLI |
|---|---|---|
| Founded | 2007 | 2013 |
| Country | United States | United States |
| Employees | 439 | N/A |
| Industry | Investment Bankers/Brokers/Service | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.5B | 3.0B |
| IPO Year | N/A | 2017 |
Fundamental Metrics
Financial Performance| Metric | MIAX | DNLI |
|---|---|---|
| Price | $42.78 | $20.19 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 7 | 13 |
| Target Price | ★ $47.00 | $34.27 |
| AVG Volume (30 Days) | 1.1M | ★ 1.7M |
| Earning Date | 05-19-2026 | 05-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $12.02 | $444.50 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $31.20 | $12.31 |
| 52 Week High | $51.38 | $23.77 |
Technical Indicators
Market Signals| Indicator | MIAX | DNLI |
|---|---|---|
| Relative Strength Index (RSI) | 62.27 | 52.13 |
| Support Level | $41.36 | $18.42 |
| Resistance Level | $43.21 | $20.35 |
| Average True Range (ATR) | 1.34 | 1.20 |
| MACD | 0.49 | 0.01 |
| Stochastic Oscillator | 87.29 | 42.68 |
Price Performance
Historical ComparisonAbout MIAX Miami International Holdings Inc.
Miami International Holdings Inc is engaged in operating regulated financial marketplaces across multiple asset classes using proprietary technology platforms. The company operates exchange markets for options, equities, futures, and international listings through its MIAX Exchanges, MIAX Futures Exchange, and the Bermuda Stock Exchange. The company operates through four reportable segments: Options, which provides trading and market data services for listed equity and ETP options; Equities, which provides trading services for U.S. equities and ETPs; Futures, which provides futures trading and clearing services through MIAX Futures; and International, which provides listing services for capital market instruments through the Bermuda Stock Exchange and The International Stock Exchange.
About DNLI Denali Therapeutics Inc.
Denali Therapeutics Inc is a biotechnology company that is engaged in developing and discovering therapeutics to defeat neurodegenerative diseases. The company's development programs include the LRRK2 Inhibitor Program, which develops brain penetrant small molecule LRRK2 inhibitor product candidates for Parkinson's disease. Its key products include DNL201, DNL151, ATV (Antibody Transport Vehicle), ETV (Enzyme Transport Vehicle), and others. The Company has one operating segment with the goal to discover, develop, and commercializing therapeutics.